Cargando…

Prediction tools in non-muscle invasive bladder cancer

Non-muscle invasive bladder cancer (BCa) is the second most common genitourinary malignancy, burdened by high rates of recurrence and progression. Urologist are encouraged to stratify patients on the bases of recurrence and progression risks in order to define the best therapeutic approach and follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamboni, Stefania, Moschini, Marco, Simeone, Claudio, Antonelli, Alessandro, Mattei, Agostino, Baumeister, Philipp, Xylinas, Evanguelos, Hakenberg, Oliver W., Aziz, Atiqullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414347/ https://www.ncbi.nlm.nih.gov/pubmed/30976567 http://dx.doi.org/10.21037/tau.2019.01.15

Ejemplares similares

Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?
por: Zamboni, Stefania, et al.
Publicado: (2019)

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

The contemporary role and impact of urine-based biomarkers in bladder cancer
por: Duquesne, Igor, et al.
Publicado: (2017)

Frailty impact on postoperative complications and early mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review
por: Ornaghi, Paola I., et al.
Publicado: (2020)

Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer
por: Nowak, Łukasz, et al.
Publicado: (2021)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
por: Peyrottes, Arthur, et al.
Publicado: (2021)

Active surveillance for non-muscle invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Multiparametric magnetic resonance imaging ultrasound-guided fusion biopsy during active surveillance: A single-centre study
por: Röthlin, Kilian, et al.
Publicado: (2020)

The need to improve TURB: a diagnostic and therapeutic fundamental first step in the disease’s management
por: Moschini, Marco, et al.
Publicado: (2019)

Immunonutrition in radical cystectomy: a novel approach to reduce postoperative complications?
por: Aziz, Atiqullah, et al.
Publicado: (2018)

Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group
por: Marcq, Gautier, et al.
Publicado: (2022)

Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases
por: Moschini, Marco, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
por: Nguyen, Thanh-Tuan, et al.
Publicado: (2018)

Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review
por: Duquesne, Igor, et al.
Publicado: (2019)

Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors
por: Krajewski, Wojciech, et al.
Publicado: (2021)

Contemporary surgical and technical aspects of transurethral resection of bladder tumor
por: Ouzaid, Idir, et al.
Publicado: (2019)

The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review
por: Carando, Roberto, et al.
Publicado: (2020)

Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis
por: Moschini, Marco, et al.
Publicado: (2020)

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

Effect of bladder filling volume on detrusor contractility in men with bladder outlet obstruction
por: Hermieu, Nicolas, et al.
Publicado: (2022)

Nerve-sparing Robot-assisted Retroperitoneal Lymph Node Dissection: The Monoblock Technique
por: Afferi, Luca, et al.
Publicado: (2021)

Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
por: Roumiguié, Mathieu, et al.
Publicado: (2020)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Editorial: Optimal perioperative management of urothelial carcinoma
por: Holzman, Ariane, et al.
Publicado: (2023)

Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes
por: Moschini, Marco, et al.
Publicado: (2019)

Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis
por: Courboin, Etienne, et al.
Publicado: (2023)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer—narrative review
por: Piszczek, Radosław, et al.
Publicado: (2020)

Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study
por: Passoni, Niccolò M., et al.
Publicado: (2016)

Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
por: D’Andrea, David, et al.
Publicado: (2021)

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
por: Abufaraj, Mohammad, et al.
Publicado: (2016)

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Pones, Mario, et al.
Publicado: (2021)

Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice
por: Bögemann, Martin, et al.
Publicado: (2023)

A New Tool for Distinguishing Muscle Invasive and Non-Muscle Invasive Bladder Cancer: The Initial Application of Flexible Ultrasound Bronchoscope in Bladder Tumor Staging
por: Xu, Chuanliang, et al.
Publicado: (2014)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mas1rmof0d9d48lsqk0l50v5ce